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hospital care group. In addition, patient satisfaction in
the CR groups, as measured in the survey, held a signif-
icant improvement in overall QoL (p = 0.000) compared to
the standard hospital care group.
Conclusions: This study observed a complete disap-
pearance of symptoms and sign of improvements in the
heart beats, SBP and DBP after resistance training. This
type of CR using a moderate intensity exercise pro-
gramme proved to improve QoL, physical activities and
worth implementing in selected categories of patients.
http://dx.doi:10.1016/j.jsha.2012.06.232
Relationship of apolipoprotein E polymorphism
with lipid profiles in atherosclerotic coronary
artery disease
Ibrahim Elmadbouh, Yasser Elghobashy, Eman
Abd-Allah, Ashraf Reda, Adnan Fathe, Safaa Tayel,
Tarek Abd-Elhakim
Objective and Background: The aim was to deter-
mine the relation of apolipoprotein E (ApoE) gene poly-
morphism with lipid profile in patients with coronary
artery diseases (CAD) and its role in prediction of the
severity of carotid and coronary atherosclerosis.
Methods: One hundred patients were classified by
coronary angiography: 80 patients with CAD and 20 con-
trols (normal coronary angiography). Clinical data, caro-
tid sonography, blood lipid profiles and ApoE
genotyping (PCR-RFLP) were assessed.
Results: CAD patients had significantly increased in
plasma lipid profiles and carotid intimal-wall thickness
(IMT) versus controls. In CAD patients, ApoE genotypes
frequencies were E3/E3 = 62.50%, E2/E3 = 18.75%, E3/
E4 = 17.50%, E2/E4 = 1.25%, E4/E4 = 0.0% and E2/
E2 = 0.0%. But, E3/E4 genotype was significantly higher
than controls (p < 0.05). Also, in CAD patients, ApoE
alleles frequencies were E3 = 80.6%, E2 = 10.0% and
E4 = 9.4% but, ApoE4 alleles was associated with higher
cholesterol (p < 0.05) and LDL-c (p < 0.01), while ApoE2
alleles was associated with higher triglycerides (p < 0.05)
versus ApoE3 alleles. However, odds ratio of CAD
patients had higher risk with E2/E3 genotypes (2.5-fold),
E2 alleles (2.2-fold) and E4 alleles (2.1-fold). Moreover,
CAD patients with ApoE4 alleles had significantly higher
percentage of carotid IMT (1.23 ± 0.26 mm vs
1.10 ± 0.40 mm ApoE2; vs 0.97 ± 0.2 mm ApoE3 alleles;
p = 0.006) and left anterior descending (LAD) coronary
artery stenosis (vs ApoE2 and ApoE3 alleles; p = 0.016).
Conclusion: Ischemic patients with carotid and cor-
onary atherosclerosis had significantly higher integration
of dyslipidemia and ApoE alleles (ApoE2 with hypertri-
glyceridemia and ApoE4 with hypercholesterolemia and
higher LDL-c). ApoE polymorphism may be important
as diagnostic risk biomarker and may implicate thera-
peutic intervention in atherosclerotic ischemic patients.
http://dx.doi:10.1016/j.jsha.2012.06.233
Percutaneous coronary intervention in patients
with ischemic cardiomyopathy and viable myo-
cardium: A high dose dobutamine stress echocar-
diography study
Ihab Yassin, Said Khaled
Background: The treatment of patients with ischae-
mic cardiomyopathy is still problematic. The choice of
revascularization of these patients – especially who have
substantial viability – is not widely implemented due to
confusion about its benefit.
Objectives: This work aimed to evaluate prospec-
tively the response of left ventricular function to low as
well as high dose dobutamine in patients with ischaemic
cardiomyopathy showing substantial viability, with and
without improved resting left ventricular ejection fraction
after coronary angioplasty.
Methods: Fifty patients with ischaemic cardiomyop-
athy (LVEF 640%) and substantial viability (P2 seg-
ments) underwent low and high dose dobutamine
echocardiography before and 3 months after percutane-
ous coronary intervention.
Patients were divided into group 1, patients with, and
group 2, patients without significant improvement in
resting LVEF (5% by echocardiography) after revascular-
isation. The response of LVEF during dobutamine stress
echocardiography was compared in these two groups.
Results: Patients were matched for baseline charac-
teristics except for the history of myocardial infarction
which was more in group 2. The CCS functional class
for angina and the NYHA functional class for heart fail-
ure were both improved after PCI in both groups but
with a remarkable improvement in group 1. Myocardial
viability increased much more in group 1 than group 2
after PCI (6.3 vs. 4 viable segments before and 6.8 vs.
4.4 viable segments respectively after, p < 0.01). This
result has an impact on LVEF in both groups. Resting,
low dose and high dose dobutamine ejection fractions
in group 1 as compared to group 2 were:
34% vs. 31%, 46% vs. 41% and 34% vs. 32% respec-
tively, p < 0.001 before PCI while they were: 43% vs.
31%, 54% vs.44% and 56% vs. 46% respectively,
p < 0.001 after PCI.
So, the improvement in LVEF (P5%) was only found
in group 1 and not in group 2.
Conclusion: The LV function was improved only in
patients with improved resting LVEF and improved myo-
cardial viability after PCI.
http://dx.doi:10.1016/j.jsha.2012.06.234
Obesity in Egyptian children: Effect on cardiac
function and dimensions
Inas A. Saad, Tarek S. Ibrahim
Objectives: We aim to define the effect of obesity in
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